Oral Ketorolac for Arthroscopic Rotator Cuff Repair

University Hospitals Cleveland Medical Center44 enrolled

Overview

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Rotator Cuff Tear Postoperative Pain

Interventions

KetorolacDRUG

Oral Ketorolac

Eligibility

Sex: ALLMin age: 18 YearsMax age: 89 Years

Medical Language ↔ Plain English

Inclusion Criteria 1. Patients between the ages of 18 and 89 years old, male or female 2. Patients undergoing primary shoulder arthroscopic rotator cuff repair Exclusion Criteria 1. Patients below the age of 18 or above the age of 89 2. Illiterate or non-English speaking patients 3. Patients with contraindications to Ketorolac 4. History of alcohol of drug abuse 5. Chronic use of analgesic or psychotropic drugs 6. Known peptic ulcer disease or bleeding diathesis 7. Renal dysfunction

Locations (1)

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Outcomes

Primary Outcomes

Postoperative Visual Analog Scale Scores

The Visual Analog Scale ranges from a minimum score of 0 to a maximum score of 100. A smaller score would be considered a better outcome.

Time frame: participants were assessed at one single time point up to 8 weeks.

Secondary Outcomes

Number of Participants With Retear of Rotator Cuff Repair

Assessing retear of rotator cuff repair on postop MRI.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.